Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 2
2004 3
2005 6
2006 6
2007 1
2008 9
2009 7
2010 6
2011 16
2012 16
2013 19
2014 7
2015 10
2016 10
2017 13
2018 14
2019 11
2020 8
Text availability
Article attribute
Article type
Publication date

Search Results

148 results
Results by year
Filters applied: . Clear all
Page 1
Inhibition of the H3K4 methyltransferase SET7/9 ameliorates peritoneal fibrosis.
Tamura R, Doi S, Nakashima A, Sasaki K, Maeda K, Ueno T, Masaki T. Tamura R, et al. Among authors: maeda k. PLoS One. 2018 May 3;13(5):e0196844. doi: 10.1371/journal.pone.0196844. eCollection 2018. PLoS One. 2018. PMID: 29723250 Free PMC article.
Comparative Study of the Dose-Dependence of OATP1B Inhibition by Rifampicin Using Probe Drugs and Endogenous Substrates in Healthy Volunteers.
Takehara I, Yoshikado T, Ishigame K, Mori D, Furihata KI, Watanabe N, Ando O, Maeda K, Sugiyama Y, Kusuhara H. Takehara I, et al. Among authors: maeda k. Pharm Res. 2018 May 10;35(7):138. doi: 10.1007/s11095-018-2416-3. Pharm Res. 2018. PMID: 29748935 Clinical Trial.
Small-Dosing Clinical Study: Pharmacokinetic, Pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) Profiles of 5 Probes for OATP2B1 and BCRP.
Kashihara Y, Ieiri I, Yoshikado T, Maeda K, Fukae M, Kimura M, Hirota T, Matsuki S, Irie S, Izumi N, Kusuhara H, Sugiyama Y. Kashihara Y, et al. Among authors: maeda k. J Pharm Sci. 2017 Sep;106(9):2688-2694. doi: 10.1016/j.xphs.2017.03.010. Epub 2017 Mar 18. J Pharm Sci. 2017. PMID: 28322941
PBPK Modeling of Coproporphyrin I as an Endogenous Biomarker for Drug Interactions Involving Inhibition of Hepatic OATP1B1 and OATP1B3.
Yoshikado T, Toshimoto K, Maeda K, Kusuhara H, Kimoto E, Rodrigues AD, Chiba K, Sugiyama Y. Yoshikado T, et al. Among authors: maeda k. CPT Pharmacometrics Syst Pharmacol. 2018 Nov;7(11):739-747. doi: 10.1002/psp4.12348. Epub 2018 Sep 30. CPT Pharmacometrics Syst Pharmacol. 2018. PMID: 30175555 Free PMC article.
[Quantitative assessment of the risk of OATP1B1/1B3-mediated drug-drug interactions].
Mori D, Maeda K, Kusuhara H. Mori D, et al. Among authors: maeda k. Nihon Yakurigaku Zasshi. 2019;154(4):210-216. doi: 10.1254/fpj.154.210. Nihon Yakurigaku Zasshi. 2019. PMID: 31597901 Japanese.
Quantitative investigation of hepatobiliary transport of [11C]telmisartan in humans by PET imaging.
Maeda K, Ohnishi A, Sasaki M, Ikari Y, Aita K, Watanabe Y, Kusuhara H, Sugiyama Y, Senda M. Maeda K, et al. Drug Metab Pharmacokinet. 2019 Oct;34(5):293-299. doi: 10.1016/j.dmpk.2019.02.004. Epub 2019 Mar 9. Drug Metab Pharmacokinet. 2019. PMID: 31564410 Clinical Trial.
Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes.
Izumi S, Nozaki Y, Kusuhara H, Hotta K, Mochizuki T, Komori T, Maeda K, Sugiyama Y. Izumi S, et al. Among authors: maeda k. Mol Pharm. 2018 Jun 4;15(6):2277-2288. doi: 10.1021/acs.molpharmaceut.8b00138. Epub 2018 May 16. Mol Pharm. 2018. PMID: 29746136
Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers.
Mori D, Kashihara Y, Yoshikado T, Kimura M, Hirota T, Matsuki S, Maeda K, Irie S, Ieiri I, Sugiyama Y, Kusuhara H. Mori D, et al. Among authors: maeda k. Drug Metab Pharmacokinet. 2019 Feb;34(1):78-86. doi: 10.1016/j.dmpk.2018.09.003. Epub 2018 Sep 20. Drug Metab Pharmacokinet. 2019. PMID: 30528195 Clinical Trial.
A Clinical Cassette Dosing Study for Evaluating the Contribution of Hepatic OATPs and CYP3A to Drug-Drug Interactions.
Yoshikado T, Maeda K, Furihata S, Terashima H, Nakayama T, Ishigame K, Tsunemoto K, Kusuhara H, Furihata KI, Sugiyama Y. Yoshikado T, et al. Among authors: maeda k. Pharm Res. 2017 Aug;34(8):1570-1583. doi: 10.1007/s11095-017-2168-5. Epub 2017 May 8. Pharm Res. 2017. PMID: 28484975
148 results
Jump to page
Feedback